aTyr Pharma, Inc. ATYR
3.69 USD -0.39 (-9.56%)
Regular-session close
3.70 +0.01 +0.27%
After hours · Nov 19, 4:12 PM ET
3.69 Day range 4.21
3.69 52-week range 44.40
- YTD
- -88.22%
- 1 year
- -86.33%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 190.00K | 235.00K | 353.00K | 10.39M | 0 | |
| 190.00K | 235.00K | 353.00K | 10.39M | 0 | |
| -77.63M | -67.91M | -54.92M | -46.40M | -34.02M | |
| -74.12M | -64.02M | -50.39M | -45.34M | -33.77M | |
| -32.00 | -34.40 | -37.60 | -64.00 | -71.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 12.98M | 14.01M | 26.03M | 13.15M | 2.34M | |
| 93.00M | 96.83M | 120.65M | 95.79M | 115.54M | |
| 25.71M | 27.00M | 30.18M | 24.50M | 6.41M | |
| 12.03M | 13.28M | 15.10M | 11.53M | 1.38M | |
| 67.48M | 70.02M | 90.66M | 71.46M | 109.30M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -61.99M | -69.12M | -33.22M | -41.89M | -33.08M | |
| -5.05M | 17.23M | -20.13M | 47.24M | -91.57M | |
| 66.01M | 39.86M | 66.23M | 5.45M | 110.03M | |
| -65.00K | -58.00K | -4.20M | -1.46M | -142.00K | |
| -1.03M | -12.02M | 12.88M | 10.81M | -14.62M |
